Screener
Exponent EXPO Cost Incurred From Reimbursable Expense
Cost Incurred From Reimbursable Expense at other companies
Other financials
Where this comes from
Reported directly by Exponent in its filing.
Tagged under the XBRL concept expo:CostIncurredFromReimbursableExpense.
The source filing: Exponent’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:02 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q3 2026
- Accession
- 0001193125-26-340211
| (In thousands, except per share data) | Three Months Ended / July 3,2026 | Three Months Ended / July 4,2025 | Six Months Ended / July 3,2026 | Six Months Ended / July 4,2025 |
|---|---|---|---|---|
| Operating expenses: | ||||
| Compensation and related expenses | 100,571 | 97,474 | 191,980 | 173,377 |
| Other operating expenses | 12,865 | 12,072 | 25,690 | 24,167 |
| Reimbursable expenses | 22,752 | 9,094 | 37,238 | 17,164 |
| General and administrative expenses | 7,402 | 6,145 | 13,606 | 11,152 |
| Total operating expenses | 143,590 | 124,785 | 268,514 | 225,860 |
| Operating income | 28,022 | 17,177 | 69,401 | 61,609 |
| Other income, net: |
Item 1. Financial Statements
FAQ
- What is Exponent's cost incurred from reimbursable expense?
- Exponent (EXPO) reported cost incurred from reimbursable expense of $22.75M in Q2 2026.
- How has Exponent's cost incurred from reimbursable expense changed year-over-year?
- Exponent's cost incurred from reimbursable expense increased by 150.2% year-over-year, from $9.09M to $22.75M.
- What is the long-term trend for Exponent's cost incurred from reimbursable expense?
- Over 4 years (2021 to 2025), Exponent's cost incurred from reimbursable expense has grown at a 9.6% compound annual growth rate (CAGR), from $31.42M to $45.25M.
- What does cost incurred from reimbursable expense mean?
- Cost Incurred From Reimbursable Expense as reported by Exponent Inc.
Ask your AI about Exponent's cost incurred from reimbursable expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude